Cargando…
Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
Atherosclerosis (AS), the underlying cause of most cardiovascular events, is one of the most common causes of human morbidity and mortality worldwide due to the lack of an efficient strategy for targeted therapy. In this work, we aimed to develop an ideal biomimetic nanoparticle for targeted AS ther...
Autores principales: | Wang, Yi, Zhang, Kang, Li, Tianhan, Maruf, Ali, Qin, Xian, Luo, Li, Zhong, Yuan, Qiu, Juhui, McGinty, Sean, Pontrelli, Giuseppe, Liao, Xiaoling, Wu, Wei, Wang, Guixue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681077/ https://www.ncbi.nlm.nih.gov/pubmed/33391468 http://dx.doi.org/10.7150/thno.47841 |
Ejemplares similares
-
Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
por: Wang, Yi, et al.
Publicado: (2019) -
ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis
por: Tang, Dan, et al.
Publicado: (2021) -
RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
por: Xu, Zichen, et al.
Publicado: (2023) -
TET1s deficiency exacerbates oscillatory shear flow-induced atherosclerosis
por: Qu, Kai, et al.
Publicado: (2022) -
Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
por: Zhu, Li, et al.
Publicado: (2023)